Jan R. Boehnke<p>Talk by <span class="h-card" translate="no"><a href="https://mastodon.social/@statsepi" class="u-url mention" rel="nofollow noopener" target="_blank">@<span>statsepi</span></a></span> for those interested in <a href="https://mastodon.social/tags/PublicPolicy" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>PublicPolicy</span></a> <a href="https://mastodon.social/tags/HealthPolicy" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>HealthPolicy</span></a> and the role of clinical trials:<br><a href="https://www.youtube.com/watch?v=kISmPxhUEcM&t=1s" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">youtube.com/watch?v=kISmPxhUEc</span><span class="invisible">M&t=1s</span></a></p><p>A key point is the importance of investigator-led trials, i.e. those that do not have immediate commercial payoffs, e.g., trials investigating head to head comparisons of 2 medicines on the market; de-escalation of treatment; or those investigating <a href="https://mastodon.social/tags/healthservice" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>healthservice</span></a> practices.</p><p><a href="https://mastodon.social/tags/ResearchPolicy" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ResearchPolicy</span></a> <a href="https://mastodon.social/tags/RCT" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>RCT</span></a></p>